Pelthos Therapeutics PTHS
NYSE PTHS
$8.97 -0.40 (-4.27%)
As of: Nov 10, 2026 · 3:59 PM EST

Pelthos Therapeutics (PTHS) Asset Utilization Ratio (2025 - 2026)

Updated

Pelthos Therapeutics' (PTHS) Asset Utilization Ratio came in at 0.31 for Q2 2026, up 52.5% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Pelthos Therapeutics' Asset Utilization Ratio stood at 0.25.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.60
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.50
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.47
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.51
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.45
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.47
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.41
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.62
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Pelthos Therapeutics 32.83 Mn -55.57 Mn 11.99 Mn 0.31
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.31
Mar 31, 2026 0.20
Dec 31, 2025 0.13
API Access

Pelthos Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PTHS&period=max&api_key=YOUR_API_KEY